Details for 2013760943
Up to date per 04.04.2026
Actions
Details for 2013760943
Deleted
European Patent
07.01.2015 A
25.12.2019 B1
01.03.2012
US
201261605729 P
03.05.2012
US
201261642212 P
08.05.2012
US
201261644360 P
A61K 31/232 20060101AFI20150701BHEP
Owner
Retinagenix Therapeutics, Inc.421 Kipling Street Palo Alto, California 94301US
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
CADDEN, Suzanne4211 Sunset Blvd. North Vancouver, British Columbia V7R 3Y7CA